NGS-Based RNA-Sequencing Market Share

Statistics for the 2023 & 2024 NGS-Based RNA-Sequencing market share, created by Mordor Intelligence™ Industry Reports. NGS-Based RNA-Sequencing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of NGS-Based RNA-Sequencing Industry

The NGS-based RNA-sequencing market is moderately competitive with several players across the globe. In terms of market share, various major players currently dominate the market. With the increase in research and development activity, many regional players are expected to be part of the NGS-Based RNA-Sequencing Market over the forecast period. Some of the major players in the market are Illumina, Inc.; Oxford Nanopore Technologies; Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; PerkinElmer, Inc.; F. Hoffmann-La Roche Ltd.; Hamilton Company; and Takara Bio, Inc., among others.

NGS-based RNA-Sequencing Market Leaders

  1. Illumina, Inc.

  2. Oxford Nanopore Technologies

  3. Agilent Technologies, Inc.

  4. Thermo Fisher Scientific Inc.

  5. PerkinElmer, Inc.

*Disclaimer: Major Players sorted in no particular order

NGS-based RNA Sequencing Market - cl.png

NGS-based RNA-Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)